These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9794564)

  • 1. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?
    Sommerburg O; Grune T; Hampl H; Riedel E; van Kuijk FJ; Ehrich JH; Siems WG
    Nephrol Dial Transplant; 1998 Oct; 13(10):2583-7. PubMed ID: 9794564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?
    Sommerburg O; Grune T; Hampl H; Riedel E; Ehrich JH; Siems WG
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S23-9. PubMed ID: 10746802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum concentration of cardiotoxic lipid peroxidation products in chronic renal failure in relation to severity of renal anemia.
    Siems W; Carluccio F; Grune T; Jakstadt M; Quast S; Hampl H; Sommerburg O
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S20-5. PubMed ID: 12227722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment.
    Siems W; Carluccio F; Radenkovic S; Grune T; Hampl H
    Kidney Blood Press Res; 2005; 28(5-6):295-301. PubMed ID: 16534224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration.
    Herrera J; Nava M; Romero F; Rodríguez-Iturbe B
    Am J Kidney Dis; 2001 Apr; 37(4):750-7. PubMed ID: 11273875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative damage to RBC membranes and pentose phosphate shunt activity in hemodialysis patients after suspension of erythropoietin treatment.
    Taccone-Galluci M; Lubrano R; Trapasso E; Clerico A; Latorre P; Meloni C; Morosetti M; Castello MA; Casciani CU
    ASAIO J; 1994; 40(3):M663-6. PubMed ID: 8555597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 120(6):797-803. PubMed ID: 17391740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
    House AA; Pham B; Pagé DE
    Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT; Prata MM; Barbas JV; dos Santos JP
    Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 8 Haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2010: national and centre-specific analyses.
    Webb L; Gilg J; Wilkie M
    Nephron Clin Pract; 2012; 120 Suppl 1():c145-74. PubMed ID: 22964566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress, inflammation and nutritional status during darbepoetin alpha treatment in peritoneal dialysis patients.
    Malgorzewicz S; Lichodziejewska-Niemierko M; Lizakowski S; Liberek T; Lysiak-Szydlowska W; Rutkowski B
    Clin Nephrol; 2010 Mar; 73(3):210-5. PubMed ID: 20178720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
    Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
    Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.
    Winearls CG; Oliver DO; Pippard MJ; Reid C; Downing MR; Cotes PM
    Lancet; 1986 Nov; 2(8517):1175-8. PubMed ID: 2877323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress in hemodialysis patients treated with a dialysis membrane which has alpha-tocopherol bonded to its surface.
    Sommerburg ; Sostmann K; Grune T; Ehrich JH
    Biofactors; 1999; 10(2-3):121-4. PubMed ID: 10609872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood 8-hydroxy-2'-deoxyguanosine is associated with erythropoietin resistance in haemodialysis patients.
    Kato A; Odamaki M; Hishida A
    Nephrol Dial Transplant; 2003 May; 18(5):931-6. PubMed ID: 12686667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and carnitine supplementation in hemodialyzed patients.
    Kletzmayr J; Mayer G; Legenstein E; Heinz-Peer G; Leitha T; Hörl WH; Kovarik J
    Kidney Int Suppl; 1999 Mar; 69():S93-106. PubMed ID: 10084293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK Renal Registry 13th Annual Report (December 2010): Chapter 9: haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2009: national and centre-specific analyses.
    Gilg J; Webb L; Feest T; Fogarty D
    Nephron Clin Pract; 2011; 119 Suppl 2():c149-77. PubMed ID: 21894032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK Renal Registry 16th annual report: chapter 10 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2012: national and centre-specific analyses.
    Rao A; Gilg J; Williams A
    Nephron Clin Pract; 2013; 125(1-4):183-208. PubMed ID: 24662174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.